Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
PZ HTL SA
GLOBETECH PUBLISHING LLC

Sugar Solution Turns Tissues See-Through

By BiotechDaily International staff writers
Posted on 09 Jul 2013
Image: Various mouse tissues before and after immersion in SeeDB (Photo courtesy of RIKEN).
Image: Various mouse tissues before and after immersion in SeeDB (Photo courtesy of RIKEN).
A new study describes a sugar and water-based solution that turns tissues transparent in just three days, without disrupting the shape and chemical nature of the samples.

Researchers at the RIKEN Center for Developmental Biology (Kobe, Japan), Kyoto University (Japan), and the Japan Science and Technology Agency (JST; Saitama, Japan) have developed SeeDB, an aqueous fructose optical clearing agent they used to turn mouse embryos and brains transparent in just three days, without damaging the fine structures of the samples or the fluorescent dyes they had injected in them, allowing visualization of the neuronal circuitry at the whole-brain scale under a customized fluorescence microscope without making mechanical sections through the brain.

Combined with two-photon microscopy and an optimized objective lens, the researchers were also able to image the mouse brain from the dorsal to the ventral side, describing the detailed wiring patterns of commissural fibers connecting the right and left hemispheres of the cerebral cortex in three dimensions (3D) and were also able to visualize the 3D wiring of mitral cells in the olfactory bulb (which is involved the detection of smells), at single-fiber resolution. The study was published online on June 23, 2013, in Nature Neuroscience.

“Our simple and efficient method is useful for imaging intact morphological architecture at large scales in both the adult and developing brains,” concluded lead author Takeshi Imai, PhD, of RIKEN, and colleagues. “Because SeeDB is inexpensive, quick, easy and safe to use, and requires no special equipment, it will prove useful for a broad range of studies, including the study of neuronal circuits in human samples.”

Tissue optical clearing techniques provide a prospective solution for the application of advanced optical methods in life sciences, including physical methods, chemical-penetration enhancers, and a combination of methods. Difference in the diffusion and/or clearing ability of different clearing agents for soft or hard tissue can aid in-vivo imaging and phototherapy, as well as providing a highly sensitive indicator of tissue health or pathology condition.

Related Links:

RIKEN Center for Developmental Biology
Kyoto University
Japan Science and Technology Agency



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: Disruption and removal of malaria parasites by the experimental drug (+)-SJ733 (Photo courtesy of the University of California, San Francisco).

Experimental Antimalaria Drug Induces the Immune System to Destroy Infected Red Blood Cells

An experimental drug for the treatment of malaria was found to induce morphological changes in infected erythrocytes that enabled the immune system to recognize and eliminate them. Investigators at... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.